Artivion to Participate in the 22nd Annual Needham Virtual Healthcare Conference

Artivion, Inc. (NYSE: AORT) announced its participation in the 22nd Annual Needham Virtual Healthcare Conference, scheduled for April 18, 2023 at 8:45 a.m. ET.

Rhea-AI Summary

Artivion, Inc. (NYSE: AORT) announced its participation in the 22nd Annual Needham Virtual Healthcare Conference, scheduled for April 18, 2023 at 8:45 a.m. ET. The company's virtual fireside chat will focus on advancements in cardiac and vascular surgery for aortic diseases.

A live webcast will be available on Artivion's website, with an archived version accessible for 90 days. Headquartered in Atlanta, Georgia, Artivion specializes in solutions for cardiac and vascular surgeons, offering products such as aortic stents, surgical sealants, On-X mechanical heart valves, and implantable human tissues, distributed in over 100 countries.

Argus Session date unavailable

+3.28% session move Open Argus

Details

News Market Reaction – AORT

The recorded move for AORT in the trading session of this news was +3.28%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ATLANTA, April 10, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming 22^nd Annual Needham Virtual Healthcare Conference. The Company's virtual fireside chat is scheduled to begin at 8:45 a.m. ET on April 18, 2023.  

A live webcast of the virtual fireside chat will be accessible through Artivion's website, www.artivion.com, on the Investors page.  An archived copy of the webcast will be available for 90 days on the same website. 

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stents and stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:
Artivion		Gilmartin Group LLC
D. Ashley Lee		Brian Johnston / Lynn Lewis
Executive Vice President and		Phone: 332-895-3222
Chief Financial Officer		investors@artivion.com
Phone: 770-419-3355

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-the-22nd-annual-needham-virtual-healthcare-conference-301793567.html

SOURCE Artivion, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Artivion participating in the Needham Virtual Healthcare Conference?

Artivion will participate in the Needham Virtual Healthcare Conference on April 18, 2023, at 8:45 a.m. ET.

How can I access Artivion's webcast from the conference?

The live webcast of Artivion's presentation will be available on their website under the Investors page.

What is Artivion's stock symbol?

Artivion's stock symbol is AORT.

What products does Artivion focus on?

Artivion focuses on developing products for aortic disease treatment, including stents, surgical sealants, heart valves, and human tissues.

Where is Artivion headquartered?

Artivion is headquartered in Atlanta, Georgia.